Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Journal.
Press releases published on October 14, 2025
ExGen Resources Announces Arrangements to Address Mailing Delays Resulting from Canada Post Strike
VANCOUVER, British Columbia, Oct. 14, 2025 (GLOBE NEWSWIRE) -- ExGen Resources Inc. (TSX.V: EXG; OTC: BXXRF) (“ExGen”, the “Company”) wishes to provide an update to shareholders on the impact of the strike by the Canadian Union of Postal Workers on the …
Micropolis and Dubai Police Announce Official Deployment of the Autonomous Police Patrol at Global Village
DUBAI, United Arab Emirates, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Dubai Police and Micropolis Holding Co. (“Micropolis”, “Micropolis Robotics”, or the “Company”) (NYSE: MCRP), a pioneer in unmanned ground vehicles and AI-driven security solutions, today …
EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases
Press Release EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases Through this funding round, the company will initiate the clinical development of its first therapeutic candidate, EVerGel, in 2026, and will enhance its …
NEVADA CANYON ANNOUNCES SIGNIFICANT GOLD INTERCEPTS INCLUDING 21.8 G/T AU OVER 4.6 METERS REPORTED AT THE LAPON CANYON GOLD PROJECT
Reno, Nevada, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Nevada Canyon Gold Corp. (OTCQX: NGLD) (the “Company” or “Nevada Canyon”) is pleased to announce the release of additional drill results from the 2025 reverse circulation (“RC”) drill program on the Lapon …
Dewpoint Therapeutics Announces Presentation at AACR-NCI-EORTC 2025
Dewpoint will present one poster at AACR-NCI-EORTC MYC is a highly desirable oncogenic target that historically eluded drug hunters Small molecules that inhibit the oncogenic function of MYC were discovered using Dewpoint’s AI/ML and condensate science …
GoldHaven Completes Non-Brokered Private Placement
VANCOUVER, British Columbia, Oct. 14, 2025 (GLOBE NEWSWIRE) -- GoldHaven Resources Corp. (“GoldHaven” or the “Company”) (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS), a Canadian resource sector exploration and development company is pleased to announce that has …
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference
SOUTH SAN FRANCISCO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Maxus Mining and Palliser Exploration Complete Successful 2025 Exploration Programs Across Four Critical Mineral Properties
VANCOUVER, British Columbia, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce the completion of the 2025 ground exploration program (the “Program”) across its four critical …
Aventis Energy Announces Appointment of Chris Fozard as Technical Advisor
VANCOUVER, British Columbia, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Aventis Energy Inc. (“Aventis” or the “Company”) (CSE:AVE | FRA:C0O0 | OTC: VBAMF) is pleased to announce the appointment of Mr. Chris Fozard as a Technical Advisor to the Company. Mr. Fozard …
Copper Quest Amends RIP Cu-Mo Option Agreement and Provides Project Update
VANCOUVER, British Columbia, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company”) is pleased to announce that it has signed an Amended Option Agreement (the “Amendment …
Halda Therapeutics Announces Oral Plenary Presentation on HLD-0915 Clinical Data in Metastatic Castration-Resistant Prostate Cancer (mCRPC) at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics on October 24, 2025
BOSTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Halda Therapeutics today announced that new clinical data on HLD-0915, the company’s first-in-class oral RIPTAC™ therapeutic, will be presented at the plenary session of the 2025 AACR-NCI-EORTC International …
Skyharbour’s Partner North Shore Uranium Completes Prospecting Program at the Falcon Project; Significant Radioactivity Discovered in Outcrops and Boulders
Vancouver, BC, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”), is pleased to announce that its partner company, North Shore Uranium (“North Shore”), has completed a …
Ashvattha Therapeutics Appoints Ophthalmology Veteran Robert J. Dempsey as Interim CEO Following Positive Phase 2 Results and FDA Alignment on Pivotal Program
FDA agrees with Phase 2b/3 clinical design, including primary endpoint and development approach, providing clear regulatory pathway to conduct two studies under single protocol Dempsey brings proven track record of ophthalmology commercialization and will …
WALKER RIVER ANNOUNCES SIGNIFICANT GOLD INTERCEPTS INCLUDING 21.8 G/T AU OVER 4.6 METERS AT THE LAPON CANYON GOLD PROJECT
Vancouver, B.C., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Walker River Resources Corp. (“Walker” or the “Company”) (TSX-V: WRR) is pleased to announce additional assay results from its ongoing reverse circulation (“RC”) drill program at the Lapon Canyon portion …
Fate Therapeutics Expands Leadership Team with Appointment of Kamal Adawi as Chief Financial Officer
SAN DIEGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE) (the Company), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular …
Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek
CAMBRIDGE, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial …
Cabaletta Bio Announces Appointment of Steve Gavel as Chief Commercial Officer and Award of Inducement Grant
– Gavel brings highly relevant CAR T experience from Legend Biotech where he led the launch and commercialization of CARVYKTI® from 2018 until 2025 – PHILADELPHIA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage …
Integral Metals Upsizes Private Placement to up to C$3M
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce that it …
Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
DOYLESTOWN, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while …